Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex

Virology ◽  
1987 ◽  
Vol 160 (1) ◽  
pp. 151-161 ◽  
Author(s):  
Gary R. Pearson ◽  
Janos Luka ◽  
Lisa Petti ◽  
Jeffery Sample ◽  
Mark Birkenbach ◽  
...  
1983 ◽  
Vol 47 (1) ◽  
pp. 193-201 ◽  
Author(s):  
G R Pearson ◽  
B Vroman ◽  
B Chase ◽  
T Sculley ◽  
M Hummel ◽  
...  

1983 ◽  
Vol 32 (3) ◽  
pp. 307-314 ◽  
Author(s):  
Gottfried Dölken ◽  
Winand Lange ◽  
Ulrike Weitzmann ◽  
Friedrich W. Hirsch ◽  
Georg W. Löhr

Blood ◽  
1993 ◽  
Vol 82 (3) ◽  
pp. 872-876 ◽  
Author(s):  
P Brousset ◽  
H Knecht ◽  
B Rubin ◽  
E Drouet ◽  
S Chittal ◽  
...  

Epstein-Barr virus (EBV) is detectable in approximately 40% of cases of Hodgkin's disease (HD). The viral genomes remain latent but positive staining with anti-ZEBRA antibody in a small fraction of Reed-Sternberg (RS) cells of some cases of HD would suggest possible activation of EBV replication within these cells. We report the investigation of 40 cases of EBV-associated HD (including 5 human immunodeficiency virus [HIV]- positive cases) using anti-ZEBRA antibodies. Positive staining was found in only three (HIV-negative) cases. One of these three cases showed approximately 1% of ZEBRA-positive tumor cells, whereas the other two cases showed rare positive cells. In the case with 1% ZEBRA- positive cells, a strong signal was obtained with anti-EA-R antibody and BHLF1 oligoprobes, which indicated early gene expression. EBV replication could be shown in this case by nonisotopic in situ DNA-DNA hybridization, which showed markedly increased numbers of EBV genomes in a few RS cells. Viral replication was confirmed using reverse transcriptase and polymerase chain reaction that detected transcripts from the BLLF1 gene encoding for the membrane antigen gp350/220. EBV replication in RS cells seems to be an exceptional event but may provide clues to mechanisms of control of viral latency and assume clinical implications in the future.


Blood ◽  
1993 ◽  
Vol 82 (3) ◽  
pp. 872-876 ◽  
Author(s):  
P Brousset ◽  
H Knecht ◽  
B Rubin ◽  
E Drouet ◽  
S Chittal ◽  
...  

Abstract Epstein-Barr virus (EBV) is detectable in approximately 40% of cases of Hodgkin's disease (HD). The viral genomes remain latent but positive staining with anti-ZEBRA antibody in a small fraction of Reed-Sternberg (RS) cells of some cases of HD would suggest possible activation of EBV replication within these cells. We report the investigation of 40 cases of EBV-associated HD (including 5 human immunodeficiency virus [HIV]- positive cases) using anti-ZEBRA antibodies. Positive staining was found in only three (HIV-negative) cases. One of these three cases showed approximately 1% of ZEBRA-positive tumor cells, whereas the other two cases showed rare positive cells. In the case with 1% ZEBRA- positive cells, a strong signal was obtained with anti-EA-R antibody and BHLF1 oligoprobes, which indicated early gene expression. EBV replication could be shown in this case by nonisotopic in situ DNA-DNA hybridization, which showed markedly increased numbers of EBV genomes in a few RS cells. Viral replication was confirmed using reverse transcriptase and polymerase chain reaction that detected transcripts from the BLLF1 gene encoding for the membrane antigen gp350/220. EBV replication in RS cells seems to be an exceptional event but may provide clues to mechanisms of control of viral latency and assume clinical implications in the future.


1993 ◽  
Vol 53 (2) ◽  
pp. 199-204 ◽  
Author(s):  
Susan Pothen ◽  
Tin Cao ◽  
Richard Smith ◽  
Paul H. Levine ◽  
Alexandra Levine ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document